XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Operating Activities    
Net income $ 509.4 $ 429.6
Adjustments to reconcile net income to net cash provided by (used for) operations:    
Depreciation 172.0 178.9
Amortization 166.8 166.1
Other intangible assets impairment charge 0.0 150.4
Share-based compensation expense 11.3 15.2
Gain on divestitures - net (1.6) (9.6)
Other noncash adjustments – net 26.2 12.3
Make-whole payments included in financing activities 0.0 7.0
Defined benefit pension contributions (72.8) (3.9)
Changes in assets and liabilities:    
Trade receivables (10.7) (30.7)
Inventories (154.6) (131.0)
Other current assets 69.4 22.5
Accounts payable 46.3 (15.2)
Accrued liabilities 26.2 (35.8)
Income and other taxes (39.9) (14.9)
Other – net 2.6 1.7
Net Cash Provided by (Used for) Operating Activities 750.6 742.6
Investing Activities    
Additions to property, plant, and equipment (332.3) (244.5)
Proceeds from divestitures – net 1.6 130.2
Other – net 23.9 (17.6)
Net Cash Provided by (Used for) Investing Activities (306.8) (131.9)
Financing Activities    
Short-term borrowings (repayments) – net (185.2) 11.7
Proceeds from long-term debt 0.0 797.6
Repayments of long-term debt, including make-whole payments 0.0 (1,157.0)
Capitalized debt issuance costs 0.0 (10.4)
Quarterly dividends paid (321.8) (311.1)
Purchase of treasury shares (8.0) (7.7)
Proceeds from stock option exercises 7.8 16.2
Other – net (2.2) 0.3
Net Cash Provided by (Used for) Financing Activities (509.4) (660.4)
Effect of exchange rate changes on cash (0.1) (0.3)
Net increase (decrease) in cash and cash equivalents (65.7) (50.0)
Cash and cash equivalents at beginning of period 169.9 334.3
Cash and Cash Equivalents at End of Period $ 104.2 $ 284.3